Donate Now - Biomarkers Consortium - Plasma Aβ as a Predictor of Amyloid Positivity in Alzheimer's Disease

The goal of this project is to perform an independent validation of the top performing blood plasma Aβ assays and determine which are the most robust in terms of having a high degree of correlation with amyloid PET or CSF Aβ levels. The desired outcome is to offer the research community guidance on which assays might help streamline clinical trials and aid in AD diagnosis.

Front Page: